Pre-open movers
U.S. stock futures traded slightly lower in early pre-market trade on Friday after the Wall Street recorded its worst first half in over 50 years.
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.